COMMUNIQUÉS West-GlobeNewswire

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/06/2026
CAMBRIDGE, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the [...]
Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes
11/06/2026
In a post hoc analysis, patients treated with roxadustat showed a durable and clinically meaningful improvement in transfusion independence (TI) in patients with LR-MDS and high transfusion burden (HTB) compared to [...]
Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
11/06/2026
PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
11/06/2026
LEXINGTON, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that Alfred W. [...]
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
11/06/2026
– Multi-organ system and quality-of-life benefits sustained through five years of treatment – 82% response rate for the multi-component endpoint – 95% of patients completed five years of treatment COPENHAGEN, Denmark, [...]
Treace to Present at the Sidoti Small Cap Conference
11/06/2026
PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
LifeLabs Recognized Once Again by Forbes as One of Canada’s Best Employers for 2026
11/06/2026
Toronto, Ontario, June 11, 2026 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce that we have been named as one of Canada’s Best Employers for 2026 by Forbes Canada. This award is determined by an independent survey of [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
11/06/2026
Company Announcement COPENHAGEN, Denmark; June 11, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 15,894 restricted stock units and 15,494 warrants to employees of the [...]
Priority Partners Receives Inaugural “Impact of Excellence Award”
11/06/2026
Living Word Seventh-Day Adventist Church Honors Medicaid Plan’s Commitment to Reducing Food Insecurity and Expanding Health Care Access HANOVER, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Priority Partners, one of Maryland’ [...]
Human Continuum Closes Over $5 Million in Seed Round Funding to Support the Development of its Integrated Exosome-Based Therapeutic Longevity Platform
11/06/2026
Jupiter, F.L., June 11, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”) , a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced that it has closed a [...]
Ally Medical ER Opens Its Doors in Frisco
11/06/2026
Ally Medical Emergency Room is now open in one of Texas’s fastest-growing cities, bringing 24/7 five-star emergency care to Frisco families FRISCO, Texas, June 11, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room [...]
Applied Biologics Launches Preclinical Development Program Focused on Osteoarthritis and Other Degenerative Diseases
11/06/2026
SCOTTSDALE, Ariz., June 11, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
11/06/2026
- Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027 - Azora’s [...]
Primeadine® Longevity Supplement Named Wellness Innovation of the Year in the 2026 Mindful Awards
11/06/2026
Oxford Healthspan Recognized for Bringing Spermidine and Longevity Science into the Mainstream Wellness Conversation SHERIDAN, Wyo., June 11, 2026 (GLOBE NEWSWIRE) -- Oxford Healthspan announced today that Primeadine [...]
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
11/06/2026
Approval is based on results from the OASIS 4 trial, which investigated semaglutide tablets 25 mg in adults living with obesity and overweight versus placebo in addition to diet and exercise Semaglutide tablets will be [...]
Novo Nordisk A/S: IT Security incident at Novo Nordisk
11/06/2026
Bagsværd, Denmark, 11 June 2026 – Novo Nordisk A/S has identified an IT security incident involving unauthorised access to a limited number of internal IT systems. Upon learning of the incident, we launched an [...]
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
11/06/2026
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply [...]
Spectral AI to Participate in 2026 British Burn Association Annual Conference
11/06/2026
Company Will Showcase FDA-Cleared DeepView® System for Burn Indication DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) [...]
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
11/06/2026
IRVINE, Calif., June 11, 2026 (GLOBE NEWSWIRE) -- Ambros Therapeutics, Inc., today announced the appointment of Cris Calsada as Chief Financial Officer (CFO) and Claire Padgett, Ph.D., as Senior Vice President (SVP) of [...]

Pages